Effects of Fusarium moniliforme isolates on tissue and serum sphingolipid concentrations in horses

Veterinary and Human Toxicology

Volumn 38, Issue 4, 1996, Pages 265-270

  Goel, S ^a   Schumacher, J ^a   Lenz, S D ^a   Kemppainen, B W ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; SPHINGOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DENTATE GYRUS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TISSUE LEVEL; FUSARIUM MONILIFORME; HISTOLOGY; LIPID METABOLISM; MOUSE; NONHUMAN;

ANIMALS; BRAIN; CARCINOGENS, ENVIRONMENTAL; CULTURE MEDIA; DUODENUM; ENZYME INHIBITORS; FUMONISINS; FUSARIUM; HORSE DISEASES; HORSES; INTESTINES; KIDNEY; LIVER; LUNG; MYCOTOXINS; SPHINGOSINE; TISSUE DISTRIBUTION;

ANIMALIA; EQUIDAE; FUSARIUM; GIBBERELLA FUJIKUROI; ZEA MAYS;

EID: 0029738109     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Nelson PE, Desjardins AE, Plattner RD: Fumonisins, mycotoxins produced by Fusarium species: Biology, chemistry and significance. Annu Rev Phytopathol 31: 233-252, 1993.
2. Bezuidenhout SC, Gelderblom WCA, Grost-Allman CP et al: Structure elucidation of fumonisins, mycotoxins from Fusarium moniliforme. J Chem Soc Chem Commun 11: 743-745, 1988.
3. Marasas WFO, Kellerman TS, Gelderblom WCA et al: Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort J Vet Res 55: 197-203, 1988.
4. Ross PF, Ledet AE, Owens DL et al: Experimental equine leukoencephalomalacia, toxic hepatosis and encephalopathy caused by corn naturally contaminated with fumonisins. J Vet Diag Invest 5: 69-74, 1993.
5. Wilson TM, Ross PF, Owens DL et al: Experimental reproduction of ELEM. Mycopathologia 117: 115-120, 1992.
6. Henninger RW: Proximal enteritis in a quarter horse stallion. Compend Contin Educ Pract Vet 8: S53-S58, 1986.
7. Johnston JK, Morris DD: Comparison of duodenitis/proximal jejunitis and small intestinal obstruction in horses: 68 cases (1977-1985). JAVMA 191: 849-854, 1987.
8. White NA, Tyler DE, Blackwell RB et al: Hemorrhagic fibrinonecrotic duodenitis-proximal jejunitis in horses: 20 cases (1977-1984). JAVMA 190: 311-315, 1987.
9. McClure JJ: Anterior enteritis. In Robinson NE ed: Current Therapy in Equine Medicine. WB Saunders Co, Philadelphia: 214-215, 1983.
10. McClure J, Adams R, Goff C: Fractional excretion of amylase and gamma-glutamyl transpeptidase in proximal enteritis and other conditions. Proc 2nd Equine Colic Res Symp: 117-118, 1982.
11. Merritt AM, Robbins J, Brewer B: Is Salmonella infection a cause of gastric dilation/ileus syndromes in horses? Proc 2nd Equine Res Symp: 119-124, 1982.
12. Palmer JE: Acute diarrheal diseases of the adult horse. Proc 2nd Ann Forum ACVIM: 247-250, 1984.
13. Smith BP, Reiana-Greena M, Hardy AJ: Prevalence and epizootiology of equine salmonellosis. J Am Vet Med Assoc 172: 353-356, 1978.
14. Schumacher J, Cohen ND, Seahorn TL: Duodenitis/proximal jejunitis (anterior enteritis) in horses. Compend Continu Ed Pract Vet 16: 1197-1206, 1994.
15. Wang E, Ross PF, Wilson TM et al: Increases in serum sphingosine and sphinganine and decreases in complex shingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. J Nut 122: 1706-1716, 1992.
16. Riley RT, An NH, Showker JL et al: Alteration of tissue and serum sphinganine to sphingosine ratio: An early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol Appl Pharmacol 108: 105-112, 1993.
17. 1 induces disruption of sphingolipid metabolism in Sprague Dawley rats: A new mechanism of nephrotoxicity. J Nutr 124: 594-603, 1994.
18. Goel S, Lenz SD, Lumlertdacha S et al: Sphingolipid levels in catfish consuming F moniliforme corn culture material containing fumonisins. Aquatic Toxicology 30: 285-294, 1994.
19. Terse P:. In vitro and in vivo toxicity of mycotoxins (dissertation). Auburn University, Alabama, 1995.
20. Wang E, Norred WP, Bacon CW et al: Inhibition of sphingolipid biosynthesis by fumonisins. Implications for disease associated with Fusarium moniliforme. J Biol Chem 266: 14486-14490, 1991.
21. Yoo HS, Norred WP, Wang E et al: Sphingosine inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. Toxicol Appl Pharmacol 114: 9-15, 1992.
22. Mathias S, Dressler KA, Kolesnick RN: Characterization of a ceramide-activated protein kinase: Stimulation by tumor necrosis factor α Proc Natl Acad Sci USA 88: 10009-10013, 1991.
23. Hannun YA, CR Loomis, Merrill AH et al: Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 261: 12604-12609, 1986.
24. Schroeder JJ, Cranes HM, Xia J et al: Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. J Biol Chem 269: 3475-3481, 1994.
25. Ballou LR: Sphingolipids and cell function. Immunol Today 13: 339-341, 1992.
26. Simons K, Meer G: Lipid sorting in epithelial cells. Biochemistry 27: 8197-8203, 1988.
27. Riley RT, Norred WP, Bacon CW: Fungal toxins in foods: Recent concerns. Annu Rev Nutr 13: 167-189, 1993.
28. Hatch RC: Posions causing nervous stimulation or depression. In Booth NH, McDonald LE eds: Veterinary Pharmacology and Therapeutics, 6th ed. Iowa State University Press, Iowa: 1061-1062, 1988.
29. Ramasamy S, Wang E, Henning B et al: Fumonisin B1 alters sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture. Toxicol Appl Pharmacol 133: 343-348, 1995.
30. Harel R, Futerman AH: Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons. J Biol Chem 268: 14476-14481, 1993.
31. Merrill AH, Echten G, Wang E et al: Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol Chem 268: 27299-27306, 1993.
32. Schumacher J, Mullen J, Shelby R et al: An investigation of the role of Fusarium moniliforme in duodenitis/proximal jejunitis of horses. Vet Human Toxicol 37: 39-45, 1995.
33. Shephard GS, Sydenham EW, Thiel PG et al: Quantitative determination of fumonisins B1 and B2 by high pressure liquid chromatography with fluorescence detection. J Liquid Chromatogr 13: 2077-2087, 1990.
34. Merrill AH, Wang E, Mullins RE et al: Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal Biochem 171: 373-381, 1988.
35. SAS Institute Inc: SAS/STAT Guide for personal computers. SAS Institute Inc, Cary, NC, 1985.
36. Rother J, Echten G, Schwarzmann G et al: Biosynthesis of sphingolipids: Dihydroceramide and not sphinganine is desaturated by cultured cells. Biochem Biophysic Res Com 189: 14-20, 1992.
37. 1 in male Sprague Dawley rats. Natl Toxins 1: 341-346, 1993.
38. 1 in swine. Natl Toxins 2: 73-80, 1994.
39. 1 in a non-human primate. Toxicon 32: 735-741, 19.
40. Porter JK, Voss KA, Chamberlain WJ et al: Neurotransmitters in rats fed fumonisin B1. Proc Soc Exp Biol Med 202: 360-364, 1993.
41. Lumlertdacha S: Growth, hematology, histology, and immune responses of Channel Catfish fed toxins from Fusarium moniliforme (dissertation). Auburn University, Alabama, 1994.